Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0K9NW
|
|||
Former ID |
DNC012625
|
|||
Drug Name |
4-(3,4-Dihydro-1H-isoquinolin-2-yl)-quinoline
|
|||
Synonyms |
CHEMBL50166; 4-(3,4-Dihydro-1H-isoquinolin-2-yl)-quinoline; SCHEMBL6159581; ZINC26870; BDBM50127827
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C18H16N2
|
|||
Canonical SMILES |
C1CN(CC2=CC=CC=C21)C3=CC=NC4=CC=CC=C43
|
|||
InChI |
1S/C18H16N2/c1-2-6-15-13-20(12-10-14(15)5-1)18-9-11-19-17-8-4-3-7-16(17)18/h1-9,11H,10,12-13H2
|
|||
InChIKey |
HRDFYQVITWAQGZ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | 4-(3,4-dihydro-1H-isoquinolin-2yl)-pyridines and 4-(3,4-dihydro-1H-isoquinolin-2-yl)-quinolines as potent NR1/2B subtype selective NMDA receptor an... Bioorg Med Chem Lett. 2003 May 19;13(10):1759-62. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.